SecBot SecBot
8-K ·Filed May 13, 2026
QT

QTIWW

QT IMAGING HOLDINGS, INC.
MIXED
Impact 5/10
Horizonweeks Processed5mo ago SEC0001628280-26-034379
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

Revenue growth is robust and guidance intact, but margin compression and cash burn are headwinds. Watch for Q2 2026 shipment pace and any updates to gross margin trajectory as leading indicators of whether the $39M target and path to profitability are achievable.

DirectionMixed
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

QT Imaging reports Q1 2026 revenue of $6.5M, up 133% YoY, in line with consensus. Gross margin fell to 41% from 65%, operating loss widened to $2.3M, and adjusted EBITDA worsened to -$1.9M. The company reaffirmed full-year 2026 revenue guidance of ~$39M and extended its term loan maturity to March 2029.

Key Financial Metrics

EPS
−$0.25
Revenue
$6.5M
est $6.5M · +0.5% · +133.0% YoY
Rating
in line
Guidance
~$39 million
maintained
Free Cash Flow
-$3.7M
Gross Margin
41%

Key Facts

  • Q1 2026 revenue $6.5M, up 133% YoY from $2.8M
  • Gross margin 41% vs 65% a year ago
  • Operating loss $(2.3)M vs $(1.0)M in Q1 2025
  • Net loss $(3.4)M (($0.25)/share) vs $(11.1)M (($1.21)/share)
  • Adjusted EBITDA $(1.9)M vs $(0.9)M in prior year
  • Cash and equivalents $7.0M at March 31, 2026, down from $10.5M at Dec 31, 2025
  • Reaffirmed FY2026 revenue guidance of ~$39M
  • Extended Lynrock Lake term loan maturity to March 31, 2029; interest rate increased to 12%

Financial Impact

Revenue beat consensus by ~0.5%; cash burn narrowed sequentially but operating cash outflow totaled $3.7M in Q1.

revenuegross marginoperating losscash burn

Risk Factors

  • Cash burn may require further financing, diluting equity
  • Gross margin compression could persist due to higher scanner costs
  • Geopolitical risks in Gulf region may impact UAE distribution
  • Dependence on a few large distribution partners for revenue

Market Snapshot

Exchange
OTC
Sector
Electromedical & Electrotherapeutic Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-034379
Document: formq12026earningsrelease.htm0001628280-26-034379
Document: 0001628280-26-034379-index-headers.html0001628280-26-034379
Document: 0001628280-26-034379-index.html0001628280-26-034379
Document: 0001628280-26-034379.txt0001628280-26-034379
8-K Data (Synthetic)0001628280-26-034379
6 reports for QTIWW
Performance horizon
Filters
Rows
Reports for QTIWW — sortable, filterable
TypeNow
May 21, 2026
22w ago
8-K
BEARISH ★ 6/10
—awaiting T+20——
May 15, 2026
23w ago
424B5
BEARISH ★ 6/10
—awaiting T+20——
May 13, 2026
23w ago
8-K
MIXED ★ 5/10
—awaiting T+20——
Apr 6, 2026
29w ago
EFFECT
NEUTRAL ★ 4/10
—awaiting T+20——
Apr 1, 2026
29w ago
EFFECT
NEUTRAL ★ 4/10
—awaiting T+20——
Mar 27, 2026
30w ago
S-3
NEUTRAL ★ 4/10
—awaiting T+20——
Showing 6 of 6

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 13, 2026